Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study
Version 2 2024-05-30, 23:43Version 2 2024-05-30, 23:43
Version 1 2023-07-17, 05:08Version 1 2023-07-17, 05:08
journal contribution
posted on 2024-05-30, 23:43authored byCKH Wong, ICH Au, KTK Lau, Eric LauEric Lau, BJ Cowling, GM Leung
Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study